Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay

Individual response to immune checkpoint inhibitors (ICIs) is currently unpredictable in patients with melanoma. Recent findings highlight a striking improvement in the clinical outcomes of overweight/obese patients treated with ICIs, which seems driven, at least in part, by programmed cell death pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Incorvaia, Lorena, Rinaldi, Gaetana, Badalamenti, Giuseppe, Cucinella, Alessandra, Brando, Chiara, Madonia, Giorgio, Fiorino, Alessia, Pipitone, Angela, Perez, Alessandro, Li Pomi, Federica, Galvano, Antonio, Gristina, Valerio, Barraco, Nadia, Bono, Marco, Bazan Russo, Tancredi Didier, Toia, Francesca, Cordova, Adriana, Fanale, Daniele, Russo, Antonio, Bazan, Viviana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936535/
https://www.ncbi.nlm.nih.gov/pubmed/36818688
http://dx.doi.org/10.1177/17588359231151845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936535/
https://www.ncbi.nlm.nih.gov/pubmed/36818688
http://dx.doi.org/10.1177/17588359231151845

Ejemplares similares